東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Genome editing in drug discovery

Record Type:	Electronic resources : Monograph/item
Title/Author:	Genome editing in drug discovery/ Marcello Maresca, Sumit Deswal.
other author:	Maresca, Marcello.
Published:	Hoboken, NJ :Wiley, : 2022.,
Description:	1 online resource (x, 342 p.) :ill. (chiefly col.)
Subject:	Drug development. -
Online resource:	https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404
ISBN:	9781119671404

Genome editing in drug discovery
Genome editing in drug discovery[electronic resource] /Marcello Maresca, Sumit Deswal. - Hoboken, NJ :Wiley,2022. - 1 online resource (x, 342 p.) :ill. (chiefly col.)

Includes bibliographical references and index.

"CRISPR-Cas has revolutionized genome editing by allowing researchers to remove, alter, or add sections of the DNA sequence. By performing large scale functional genomics screens with CRISPR-Cas, scientists can identify and validate drug targets at a much faster rate. Genome editing is now part of almost every step in the drug discovery pipeline, from target identification and its validation to mechanistic studies in relevant disease models to therapeutic genome editing and disease diagnosis. Genome Editing in Drug Discovery offers comprehensive coverage of the revolution CRISPR-Cas has brought to genome editing and its impact on drug discovery. Ideal for academics, researchers, and professionals in the pharmaceutical industry; this book helps readers create better disease models, assess the safety and efficacy of drugs, discover new targets, and develop next-generation diagnostics for disease-related genes. This book provides a historical prospective on genome editing, discusses the general approaches used to make disease models, and offers practical suggestions as the technology advances"--

ISBN: 9781119671404

Standard No.: 10.1002/9781119671404doiSubjects--Topical Terms:

716904
Drug development.

LC Class. No.: RM301.25 / .G46 2022

Dewey Class. No.: 615.1/9

Genome editing in drug discovery
LDR:02247cmm a2200325 a 4500 001 2338598
003 OCoLC
005 20220429120813.0
006 m o d
007 cr cnu---unuuu
008 240605s2022 njua ob 001 0 eng
020 $a 9781119671404 $q (electronic bk.)
020 $a 111967140X $q (electronic bk.)
020 $a 9781119671398 $q (epub)
020 $a 1119671396 $q (epub)
020 $a 9781119671381 $q (ePDF)
020 $a 1119671388 $q (ePDF)
020 $z 9781119671343 $q (hbk.)
024 7 $a 10.1002/9781119671404 $2 doi
035 $a 1258041328
040 $a DLC $b eng $c DLC $d OCLCO $d OCLCF $d DG1 $d OCLCO $d UKAHL $d YDX
041 0 $a eng
050 0 4 $a RM301.25 $b .G46 2022
082 0 0 $a 615.1/9 $2 23
245 0 0 $a Genome editing in drug discovery $h [electronic resource] / $c Marcello Maresca, Sumit Deswal.
260 $a Hoboken, NJ : $b Wiley, $c 2022.
300 $a 1 online resource (x, 342 p.) : $b ill. (chiefly col.)
504 $a Includes bibliographical references and index.
520 $a "CRISPR-Cas has revolutionized genome editing by allowing researchers to remove, alter, or add sections of the DNA sequence. By performing large scale functional genomics screens with CRISPR-Cas, scientists can identify and validate drug targets at a much faster rate. Genome editing is now part of almost every step in the drug discovery pipeline, from target identification and its validation to mechanistic studies in relevant disease models to therapeutic genome editing and disease diagnosis. Genome Editing in Drug Discovery offers comprehensive coverage of the revolution CRISPR-Cas has brought to genome editing and its impact on drug discovery. Ideal for academics, researchers, and professionals in the pharmaceutical industry; this book helps readers create better disease models, assess the safety and efficacy of drugs, discover new targets, and develop next-generation diagnostics for disease-related genes. This book provides a historical prospective on genome editing, discusses the general approaches used to make disease models, and offers practical suggestions as the technology advances"-- $c Provided by publisher.
588 $a Description based on print version record.
650 0 $a Drug development. $3 716904
650 0 $a Genetic engineering. $3 530509
700 1 $a Maresca, Marcello. $3 3674645
700 1 $a Deswal, Sumit. $3 3674646
856 4 0 $u https://onlinelibrary.wiley.com/doi/book/10.1002/9781119671404